Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
Vaccines · 26.05.2023 · 11 (6) · 1030
DOI: 10.3390/vaccines11061030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 26.05.2023. Verfasst von Sakshi Bajoria und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Bill & Melinda Gates Foundation, Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
Aluminum-salt vaccine adjuvants (alum) are commercially available as micron-sized particles with varying chemical composition and crystallinity. There are reports of enhanced adjuvanticity when the alum’s particle size is reduced to the nanometer range. Previously, we demonstrated that a recombinant receptor-binding domain (RBD)-based COVID-19 vaccine candidate (RBD-J; RBD-L452K-F490W) formulated with aluminum hydroxide (Alhydrogel®; AH) and CpG 1018™ (CpG) adjuvants induced potent neutralizing antibody responses in mice yet displayed instability during storage. In this work, we evaluated whether sonication of AH to the nanometer size range (nanoAH) could further enhance immunogenicity or improve storage stability of the above formulation. The addition of CpG to nanoAH (at mouse doses), however, caused re-agglomeration of nanoAH. AH-CpG interactions were evaluated by Langmuir binding isotherms and zeta potential measurements, and stabilized nanoAH + CpG formulations of RBD-J were then designed by (1) optimizing CpG:Aluminum dose ratios or (2) adding a small-molecule polyanion (phytic acid, PA). Compared with the micron-sized AH + CpG formulation, the two stabilized nanoAH + CpG formulations of RBD-J demonstrated no enhancement in SARS-CoV-2 pseudovirus neutralizing titers in mice, but the PA-containing nanoAH + CpG formulation showed improved RBD-J storage stability trends (at 4, 25, and 37 °C). The formulation protocols presented herein can be employed to evaluate the potential benefits of the nanoAH + CpG adjuvant combination with other vaccine antigens in different animal models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
- Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Bill & Melinda Gates Foundation, Seattle, WA 98109, USA.
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
ORCID-Profile: Sakshi Bajoria, Nicholas J Mantis
Förderung
- NCI NIH HHS
- Bill & Melinda Gates Foundation
- Bill & Melinda Gates Foundation
Zitieren
APA
Bajoria, S., Kumru, O. S., Doering, J., Berman, K., Slyke, G. V., Prigodich, A., Rodriguez-Aponte, S. A., Kleanthous, H., Love, J. C., Mantis, N. J., Joshi, S. B., & Volkin, D. B. (2023). Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen. Vaccines, 11(6), 1030. https://doi.org/10.3390/vaccines11061030
Vancouver
Bajoria S, Kumru OS, Doering J, Berman K, Slyke GV, Prigodich A, et al. Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen. Vaccines. 2023;11(6):1030. doi:10.3390/vaccines11061030
BibTeX
@article{Bajoria2023,
author = {Bajoria, Sakshi and Kumru, Ozan S and Doering, Jennifer and Berman, Katherine and Slyke, Greta Van and Prigodich, Anneka and Rodriguez-Aponte, Sergio A and Kleanthous, Harry and Love, J Christopher and Mantis, Nicholas J and Joshi, Sangeeta B and Volkin, David B},
title = {Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {6},
pages = {1030},
doi = {10.3390/vaccines11061030}
}
EUVIMED